Book Building
₹ - cr
₹ 0
-
₹ -
MumbaiNSE
-
-
-
Initial public offering of up to [?] equity shares of face value of Re. 1 each (Equity Shares) of Sai Life Sciences Limited (The Company or the Company) for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) (Offer Price) aggregating up to Rs. [*] crores (the Offer) comprising a fresh issue of up to [*] equity shares of face value of Re. 1 each aggregating up to Rs. 800.00 crores (the Fresh Issue) and an offer for sale of up to 61,573,120 equity shares of face value of Re. 1 each aggregating up to Rs. [*] crores (the Offer for Sale), consisting of up to 6,454,780 equity shares of face value of Re. 1 each aggregating up to Rs. [*] crores by Sai Quest Syn Private Limited (Promoter Selling Shareholder), up to 45,721,080 equity shares of face value of Re. 1 each aggregating up to Rs. [*] crores by Tpg Asia vii sf pte Ltd (TPG), up to 6,862,260 equity shares of face value of Re. 1 each aggregating up to Rs. [*] crores by hbm private equity india (collectively with tpg, Investor Selling Shareholders) and up to 2,535,000 equity shares of face value of Re. 1 each aggregating up to Rs. [*] crores by certain persons listed in this draft red herring prospectus (the Other Selling Shareholders, as defined below) (the promoter selling shareholder, investor selling shareholders and other selling shareholders, the Selling Shareholders and such equity shares, the Offered Shares). The offer includes a reservation of up to [*] equity shares of face value of Re. 1 each, aggregating up to Rs. [*] crores (constituting up to [*] % of the post-offer paid-up equity share capital, for subscription by eligible employees (Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. The offer and the net offer shall constitute [*] % and [*] % of the post-offer paid-up equity share capital of the company, respectively. The price band and the minimum bid lot shall be decided by the company.
Repayment/prepayment in full or part of all or certain outstanding borrowings availed by the company. General corporate purposes.
Sai Life Sciences Ltd, Karvy Selenium Tow-B, 31&32 Financial Dist, Nanakramguda, Hyderabad-500032
Phone - 91-40-67162222
Fax - 91-40-23001153/23420814
Email - investors@sailife.com
Website - www.sailife.com